Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.

Abstract

The purpose of this study was to evaluate the efficacy and toxicity of a single-agent, dose-intensified doxorubicin protocol in canine hemangiosarcoma (HSA). Canine HSA is a highly malignant tumor, and most affected dogs die within 6 months of diagnosis. Doxorubicin is the most, and possibly the only, effective chemotherapeutic drug for this malignancy, but… (More)

Topics

Cite this paper

@article{Sorenmo2004EfficacyAT, title={Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.}, author={Karin U. Sorenmo and Jennifer L Baez and Craig A. Clifford and Elizabeth A. Mauldin and Beth Overley and K A Skorupski and Roxanne Bachman and Marissa Samluk and Frances Shofer}, journal={Journal of veterinary internal medicine}, year={2004}, volume={18 2}, pages={209-13} }